CD8A and neoplasm: We further confirmed these results in Cln4 TCR-transgenic mice overexpressing a population of CD8+ T cells that reacts specifically to a low-avidity epitope IYSTVASSL on the model antigen hemagglutinin [45] expressed on tumor cells, RencaHA and 4T1HA.